These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23852458)

  • 41. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma.
    Dong ZR; Zhang C; Cai JB; Zhang PF; Shi GM; Gao DM; Sun HC; Qiu SJ; Zhou J; Ke AW; Fan J
    Tumour Biol; 2015 Apr; 36(4):2763-71. PubMed ID: 25480415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma.
    Kang YK; Kim WH; Jang JJ
    Hum Pathol; 2002 Sep; 33(9):877-83. PubMed ID: 12378511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of Ki-67, Bax and p73 in patients with hilar cholangiocarcinoma.
    Zhao W; Zhang B; Guo X; Zhang X; Hu J; Hu X; Lu Y
    Cancer Biomark; 2014; 14(4):197-202. PubMed ID: 24934361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
    Gu M
    Int J Clin Exp Pathol; 2015; 8(1):862-6. PubMed ID: 25755787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma.
    Kojima S; Hisaka T; Midorikawa R; Naito Y; Akiba J; Tanigawa M; Yano H; Akagi Y; Okuda K
    Anticancer Res; 2020 Aug; 40(8):4749-4754. PubMed ID: 32727801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.
    Wang J; Li J; Shen J; Wang C; Yang L; Zhang X
    BMC Cancer; 2012 Jun; 12():227. PubMed ID: 22681717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype.
    Ding YB; Deng B; Huang YS; Xiao WM; Wu J; Zhang YQ; Wang YZ; Wu DC; Lu GT; Wu KY
    Dig Dis Sci; 2013 Jun; 58(6):1627-35. PubMed ID: 23306848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance].
    Zhang BY; Zhang JY; Zhao K; Wu LQ
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):846-9. PubMed ID: 16083599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.
    Abe T; Amano H; Shimamoto F; Hattori M; Kuroda S; Kobayashi T; Tashiro H; Ohdan H
    Eur J Surg Oncol; 2015 Nov; 41(11):1515-21. PubMed ID: 26210654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
    Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
    Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.
    Kawase H; Fujii K; Miyamoto M; Kubota KC; Hirano S; Kondo S; Inagaki F
    J Proteome Res; 2009 Aug; 8(8):4092-103. PubMed ID: 19569727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
    Lee CT; Wu TT; Lohse CM; Zhang L
    Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma.
    Zhu YJ; Xu Q; Shao MY; Cao XY; Wu ZR; Chen YW; Bu H; Shi YJ
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):464-470. PubMed ID: 31402267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma.
    Gardini A; Corti B; Fiorentino M; Altimari A; Ercolani G; Grazi GL; Pinna AD; Grigioni WF; D'Errico Grigioni A
    Dig Liver Dis; 2005 Apr; 37(4):269-74. PubMed ID: 15788211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
    Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z
    Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.